Latest news with #BethIsraelDeaconess
CNN
2 days ago
- Health
- CNN
PFAS exposure before birth could put your teen at risk for high blood pressure, study finds
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being. Prenatal exposure to a class of dangerous, widely used chemicals could be linked to your child having high blood pressure as a teen, according to a new study. Perfluoroalkyl and polyfluoroalkyl substances, or PFAS — sometimes called 'forever chemicals' because they don't fully break down in the environment — are a class of about 15,000 human-made chemicals linked to cancers, endocrine-related conditions and developmental problems in children. New data shows the synthetic compounds could also be linked to a teen's risk of developing cardiovascular disease later in life, according to the study published Thursday in the Journal of the American Heart Association. Researchers looked at data from 1,094 children over an average of 12 years. The study team compared measurements of eight types of PFAS chemicals in maternal plasma samples 24 to 72 hours after birth and the children's blood pressure from medical records, according to the study. The kids who were exposed to higher levels of PFAS chemicals in utero were more likely to have higher blood pressure in childhood and adolescence, the research found. The connection was particularly strong in adolescents, male children and Black children, said senior study author Dr. Mingyu Zhang, assistant professor of medicine at Harvard Medical School and Beth Israel Deaconess Medical Center. The study is observational, meaning that while it shows associations, it cannot prove that PFAS exposure is the cause of the elevated blood pressure, Zhang said. While researchers did adjust for other factors that could be at play, there could be other elements driving the connection between PFAS and blood pressure, he added. That said, the results are strong because this study is one of the largest and most diverse while also using rigorous methods, said Dr. Carmen Marsit, Rollins Distinguished Professor of Research at Emory University's Rollins School of Public Health in Atlanta. He was not involved in the research. The topic is important to investigate because if a child has high blood pressure, they are more likely to also have higher blood pressure later on, Zhang said. And that is a risk factor for cardiovascular disease, the No. 1 cause of death in the United States. The largest effects were shown in adolescents who were exposed to a mixture of different PFAS chemicals during pregnancy compared with those who were not, which implies that there may be a synergistic impact on cardiometabolic health, Marsit said. 'Most children will be exposed to multiple different PFAS chemicals, so this is worrisome,' he said. The fact that adolescence is the age when prenatal exposure to PFAS is most linked with higher blood pressure suggests that some of the PFAS chemicals could take a long period of time to show their impacts, Marsit said. A long latency of the effects would mean that people don't just need to worry about reducing exposures, but interventions also need to be developed to prevent the health outcomes in people who were exposed earlier, he added. Not only are PFAS forever chemicals –– they also are everywhere chemicals. Data from the National Health and Nutrition Examination Survey shows that this class of chemicals can be found in nearly every person in the United States, Marsit said in a previous CNN story. There are things you can do to reduce your exposure, however, he added. Major sources of exposure include food, water, and waterproof or stain-resistant items, Marsit said. Helpful steps include drinking filtered water –– using filters like those listed by the Environmental Working Group –– out of metal or glass containers, he said. Plastics contain PFAS and other toxic chemicals, Marsit said. A focus on fresh food can also help, as packaging for foods are often coated in PFAS chemicals, he added. And avoid using nonstick cookware, opting instead for metal, cast-iron or ceramic pots and pans, he said. Dusting, vacuuming, and washing your hands before eating or drinking can also reduce PFAS exposure, Marsit said. Healthy lifestyle choices can reduce the risk of high blood pressure for children who have been exposed to PFAS, Zhang said. 'These include maintaining a healthy weight, eating a balanced diet, reducing salt intake, and encouraging physical activity,' he added. But ultimately, an individual cannot solve PFAS exposure alone, Zhang said. 'We also need policy-level actions to limit and phase out PFAS use in products and industry, and to strengthen monitoring and regulation of PFAS in water systems,' he added.
CNN
2 days ago
- Health
- CNN
PFAS exposure before birth could put your teen at risk for high blood pressure, study finds
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being. Prenatal exposure to a class of dangerous, widely used chemicals could be linked to your child having high blood pressure as a teen, according to a new study. Perfluoroalkyl and polyfluoroalkyl substances, or PFAS — sometimes called 'forever chemicals' because they don't fully break down in the environment — are a class of about 15,000 human-made chemicals linked to cancers, endocrine-related conditions and developmental problems in children. New data shows the synthetic compounds could also be linked to a teen's risk of developing cardiovascular disease later in life, according to the study published Thursday in the Journal of the American Heart Association. Researchers looked at data from 1,094 children over an average of 12 years. The study team compared measurements of eight types of PFAS chemicals in maternal plasma samples 24 to 72 hours after birth and the children's blood pressure from medical records, according to the study. The kids who were exposed to higher levels of PFAS chemicals in utero were more likely to have higher blood pressure in childhood and adolescence, the research found. The connection was particularly strong in adolescents, male children and Black children, said senior study author Dr. Mingyu Zhang, assistant professor of medicine at Harvard Medical School and Beth Israel Deaconess Medical Center. The study is observational, meaning that while it shows associations, it cannot prove that PFAS exposure is the cause of the elevated blood pressure, Zhang said. While researchers did adjust for other factors that could be at play, there could be other elements driving the connection between PFAS and blood pressure, he added. That said, the results are strong because this study is one of the largest and most diverse while also using rigorous methods, said Dr. Carmen Marsit, Rollins Distinguished Professor of Research at Emory University's Rollins School of Public Health in Atlanta. He was not involved in the research. The topic is important to investigate because if a child has high blood pressure, they are more likely to also have higher blood pressure later on, Zhang said. And that is a risk factor for cardiovascular disease, the No. 1 cause of death in the United States. The largest effects were shown in adolescents who were exposed to a mixture of different PFAS chemicals during pregnancy compared with those who were not, which implies that there may be a synergistic impact on cardiometabolic health, Marsit said. 'Most children will be exposed to multiple different PFAS chemicals, so this is worrisome,' he said. The fact that adolescence is the age when prenatal exposure to PFAS is most linked with higher blood pressure suggests that some of the PFAS chemicals could take a long period of time to show their impacts, Marsit said. A long latency of the effects would mean that people don't just need to worry about reducing exposures, but interventions also need to be developed to prevent the health outcomes in people who were exposed earlier, he added. Not only are PFAS forever chemicals –– they also are everywhere chemicals. Data from the National Health and Nutrition Examination Survey shows that this class of chemicals can be found in nearly every person in the United States, Marsit said in a previous CNN story. There are things you can do to reduce your exposure, however, he added. Major sources of exposure include food, water, and waterproof or stain-resistant items, Marsit said. Helpful steps include drinking filtered water –– using filters like those listed by the Environmental Working Group –– out of metal or glass containers, he said. Plastics contain PFAS and other toxic chemicals, Marsit said. A focus on fresh food can also help, as packaging for foods are often coated in PFAS chemicals, he added. And avoid using nonstick cookware, opting instead for metal, cast-iron or ceramic pots and pans, he said. Dusting, vacuuming, and washing your hands before eating or drinking can also reduce PFAS exposure, Marsit said. Healthy lifestyle choices can reduce the risk of high blood pressure for children who have been exposed to PFAS, Zhang said. 'These include maintaining a healthy weight, eating a balanced diet, reducing salt intake, and encouraging physical activity,' he added. But ultimately, an individual cannot solve PFAS exposure alone, Zhang said. 'We also need policy-level actions to limit and phase out PFAS use in products and industry, and to strengthen monitoring and regulation of PFAS in water systems,' he added.
WebMD
21-05-2025
- Health
- WebMD
You Could Be at Risk of IBD and Not Know It
May 21, 2025 – There's mixed news on the war against inflammatory bowel disease. Cases in the U.S. fell in the 1990s, then rose in the past 25 years. But modern medicine now has plenty of new weapons to deploy – if patients seek treatment. The term "inflammatory bowel disease" (IBD) refers to chronic conditions in the intestines, mainly Crohn's disease and ulcerative colitis. Between 2.4 million and 3.4 million Americans have IBD. It's not much of a killer – 71,628 people died of IBD-related causes between 1999 and 2022, about 3,000 per year – but in 2018, the death rate started climbing by about 10% per year, according to a new study in Clinical and Experimental Gastroenterology. Doctors are optimistic, though. "What I tell my patients is: 'There's never been a better time in human history to have Crohn's disease or ulcerative colitis because the number of available therapies has increased significantly over the last several years, and that's anticipated only to continue,' " said Loren G. Rabinowitz, MD, a gastroenterologist who specializes in IBD at Beth Israel Deaconess Medical Center. Why Is IBD on the Rise? IBD is easier than ever to find, thanks to better diagnostic tools like endoscopy, imaging, and stool tests. That could explain the rising number of cases. "We're more aware of it," said gastroenterologist Benjamin Click, MD, a professor at the University of Colorado. "We're looking more at even older people who come in with signs and symptoms and making those diagnoses potentially in populations that we may not have historically." But that's not the whole story. "The data suggests we're probably still witnessing a real rise in the incidences of not only inflammatory bowel diseases but a lot of these autoimmune conditions," said Click. Our modern way of life could be a culprit. As countries industrialize, IBD becomes more common, research finds. One explanation is the adoption of the Western diet, which is low in fruits, vegetables, grains, and fish and high in ultra-processed foods. This eating style might disturb gut bacteria and weaken the gut lining, promoting inflammation. Inflammation is normally a helpful immune response to injury or infection. But in inflammatory bowel disease, the immune system overreacts, attacking harmless gut bacteria and damaging the mucus lining of the intestines. Other potential contributors include antibiotic overexposure and smoking, researchers say. Wait, IBD Can Kill You? Don't panic: Death from IBD is rare. "Patients typically have a normal lifespan with Crohn's and ulcerative colitis," said Rabinowitz. "That's particularly true if the inflammation is treated well and treated early on, and when patients get quickly connected with a gastroenterologist who can monitor their symptoms over time." And studies might also overestimate IBD-related deaths by including cases where the condition was present but not the primary cause, said Click. But IBD can turn deadly if it progresses unchecked. Severe cases can lead to fulminant colitis, an intense and life-threatening inflammation of the colon, or bowel perforation, a hole in the small intestine or colon that lets contents leak out. IBD also raises the risk of colorectal cancer, especially when it's not well-controlled. Colorectal cancer patients with IBD tend to fare worse than those without IBD, research suggests. Inflammatory diseases including IBD have also been linked to an increased risk of diseases of the heart and blood vessels, the top killer in the U.S. and the world. It turns out that chronic gut inflammation can lead to body-wide inflammation, which can affect the blood vessels and contribute to heart problems. How Has Your IBD Risk Changed? While IBD can affect anyone at any age, a few groups stand out: Older adults. New IBD cases are rising in adults over 70, especially women, according to a study in Digestive Diseases and Sciences. While IBD used to be thought of as largely a younger person's disease, "we are diagnosing IBD in older individuals more than ever," said Click. "We also know that, in general, our population is aging, and we are seeing more individuals age with their IBD, perhaps influencing some of the epidemiologic trends." But why older women? It could simply be that women tend to have a longer lifespan, researchers say, giving them more time to develop the disease. Women. More bad news for women: While IBD-related deaths went up for everyone between 1990 and 2019, the increase was especially pronounced in women, according to a study in Annals of Gastroenterology. One possible explanation: Bias. Doctors sometimes mistake IBD symptoms for other conditions, such as irritable bowel syndrome (IBS) or hemorrhoids, and research suggests this brushoff may happen more often in women: Women with IBD were four times as likely as men to be misdiagnosed, even though symptoms were similar between the sexes. This aligns with a larger trend in medicine that women's symptoms are often downplayed or blamed on less serious disorders, especially when symptoms include weakness and pain, the researchers say. This could mean IBD is more often missed early in women, increasing the risk of serious or even fatal complications. Midwesterners. IBD is most common in Midwestern and Eastern states, the Annals of Gastroenterology study found. And IBD deaths were highest in the Midwest, especially among men, according to the Clinical and Experimental Gastroenterology study. That region has the highest population of White Americans, who historically have had the highest rates of IBD. But it was the South that saw the largest increase in IBD deaths from 1999 to 2022. The South has the country's highest Black population, researchers noted, and previous studies suggest that racial gaps in health care access could limit IBD care. Symptoms, Treatment, and the Link to Colon Cancer Catching – and treating – the condition early can lower the risk of complications, especially for Crohn's disease, Click said. What to look for: More frequent bathroom trips. Changes in the "frequency or liquidity" of your bowel movements that last for weeks should be reported to your doctor, said Rabinowitz. Stool that looks black or tarry. These can be signs of blood in your stool, which "should always prompt a discussion with your physician," she said. Bowel movements at night. This counts especially if diarrhea is regularly waking you up. Severe abdominal pain. Particularly, watch for belly pain that doesn't improve after you have a bowel movement. Unintentional weight loss. This means you're shedding pounds without trying to with diet and exercise. If you have relatives, especially siblings, with Crohn's or ulcerative colitis, seeking help is extra important. Among people who had a sibling with IBD, 1.7% developed the disorder over 10 years, compared to just 0.4% of those with no affected siblings, a study found. And if you need more motivation to get checked, there's this: Colorectal cancer is on the rise in young adults, according to the American Cancer Society. It can start with symptoms similar to IBD, such as bloody stool, diarrhea, and not being able to keep on weight. You've probably heard about the uptick in colorectal cancer in young people. Whether there's a link to the rise in IBD cases remains to be seen, said Click. Researchers are looking at several IBD risk factors tied to early life, like whether you were breastfed, antibiotic use, processed and sugar-rich diets, and exposures to smoke, pesticides, and "forever chemicals" in plastics, said Click. "If these also influence the development of early colorectal cancer, then a connection is certainly plausible." Until that research comes in, focus on evidence-backed lifestyle changes to help reduce your risk. Eat less ultra-processed and fast food and follow a Mediterranean diet, experts say. Add fermented foods – like sauerkraut or kimchi – to the mix to nourish good gut bacteria and promote a "less inflammatory microbiome," Click said. Advances in diagnosis and treatment are expected to improve IBD outcomes in the coming years. Immunosuppressive medications can reduce chronic inflammation, while steroids are often used to manage short-term flares. Regular colonoscopies can help doctors find and remove colon polyps before they have a chance to turn into cancer. Intestinal ultrasounds help doctors catch early changes in the gut. And for people at higher risk, blood tests can spot signs of IBD before symptoms arise.
Medscape
21-05-2025
- Health
- Medscape
AI vs Physicians in 2050: Happy Future or No Future?
Last February, Microsoft co-founder and billionaire philanthropist Bill Gates appeared on The Tonight Show and shared some bold predictions about artificial intelligence (AI). In just a decade, he told host Jimmy Fallon, AI will be capable of 'great medical advice' and humans will no longer be needed 'for most things.' It's not the first time we've heard claims that AI will soon replace doctors, and it's usually hard to take seriously. But then just last month, on the heels of Gates's tech forecast, researchers at Google published a study introducing Articulate Medical Intelligence Explorer (AMIE), an AI system designed for clinical interactions and diagnostic dialogue. Mike Schaekermann, MD The trial 'involved specialist physicians and patient actors [and] assessed diagnostic accuracy, communication, empathy, and management reasoning,' says Mike Schaekermann, PhD, a research scientist at Google Health involved in the study. 'AMIE often performed comparably or better than primary care physicians in these specific research settings.' Given the provided prompts, AI achieved a correct diagnosis 60% of time compared with about 34% for unassisted human doctors. It doesn't mean doctors are in danger of being replaced by AI anytime soon — now, today, in 2025 — but it does beg the question: How about in 25 years? Tech years can be like dog years. Google is already partnering with Beth Israel Deaconess Medical Center on a prospective research study, 'to explore how AMIE might help gather information previsit and understand clinician and patient perceptions in a real-world setting,' says Schaekermann. As the technology continues to advance at a sprint, and researchers continue to explore AI's applications not just as a tool but how they perform in head-to-head competitions with human physicians, is it possible that by 2050 doctors will be replaced or their roles reduced by new tech? An AI Upheaval May (or May Not) Be Coming Let's play the science fiction card. Replacing doctors with machines feels like science fiction because it feels imaginary. Today. But everything from the internet to Wi-Fi to touch-screen supercomputers in our pockets felt imaginary at one time. Science fiction-turned-facts incoming: Beckman Institute researchers recently developed an AI model that can accurately identify tumors and diseases in medical images. London's Institute of Cancer Research has created a prototype test that uses AI to predict the best drug combinations for cancer patients in less than 48 hours. King's College Hospital, also in London, is recruiting patients for a clinical trial of a new AI tool that can identify abnormalities on MRI head scans, and both Med-PaLM and ChatGPT have passed the US medical licensing exam. Luciana D'Adderio, PhD AI is already driving significant changes in stroke diagnosis, says Luciana D'Adderio, PhD, Turing Fellow with the Alan Turing Institute and founder of the behavioural AI lab at Edinburgh University's Centre for Medical Informatics. Her research, published last January, found that rather than using AI to confirm their diagnosis, clinicians could now use AI to make an initial assessment. 'Potentially, these changes can benefit patients, improving the detection rate of large vessel occlusions,' says D'Adderio, 'but perhaps more importantly by providing the clinician with immediate predictive maps of the extent of brain damage and the potential for treatment.' And it's only beginning. 'By 2050, I expect AI to be a deeply integrated, horizontal layer across the entire diagnostic pathology workflow,' says Faisal Mahmood, PhD, associate professor of pathology at Brigham and Women's Hospital and Harvard Medical School, whose lab is devoted to machine learning and data fusion. 'Routine slides will be automatically triaged, allowing pathologists to focus on complex cases. AI will preorder ancillary tests based on predictive models, and agentic, generative AI systems will serve as intelligent assistants — answering diagnostic questions, highlighting key findings, and even drafting structured pathology reports.' That feels like the feel-good scenario: a truly fast, accurate, dependable technology that augments the physician/patient interaction and improves care. Neither physicians nor patients would argue against such a future. David Dranove, PhD David Dranove, PhD, paints a less rosy picture. The Walter J. McNerney Professor of Health Industry Management at Northwestern University's Kellogg School of Management has studied how AI could change the future of healthcare and suggests that by 2050, AI could 'more than adequately substitute for the radiologist, and presumably at a much lower cost because AI can be scaled.' Humans will still be needed in medicine, if only because humans are 'vastly more capable of detecting and interpreting the nuances of each other's speech, posture, facial expressions, and so forth,' he says. 'These are essential to taking a medical history, forming a diagnosis, and making and communicating a treatment plan.' What does that mean for the medical students hoping for careers in healthcare tomorrow? 'You had better have strong people skills,' says Dranove. 'If all you can bring to your patients is book learning — knowing what tests to order and what protocols to implement based on objective data — without the ability to make subjective decisions based on differences you perceive from one patient to another, then you might as well give way to the computer.' Remember the term 'patient care,' he advises. 'If you are not good at the 'care,' then you may find yourself replaceable.' It might also be useful to look at what is currently happening in nursing, with nurses unions already rising to the defense against AI encroachment in traditional nursing roles and new data already showing that AI could be far cheaper than human nurses ($9 per hour vs $35-$40 per hour for humans). It makes sense to look at the future through the lens of basic business: If a new tech can lower costs, especially human ones, why would those cuts not be made? If a new tech can automate, streamline, and perform equally or better than a slower (human) method, why would that replacement not take place? If head-to-head doctor vs AI studies are happening now and AI is already winning, what will that competition look like in 25 years? Still, D'Adderio isn't convinced that an AI-inspired people-purge is coming. 'Human judgement remains fundamentally important,' she says. She suspects that in another few decades, people will turn to AI tools as a first resource for their medical inquiries, 'much as they already do with Google.' And AI will probably be able to retrieve multimodal data and use it to improve its predictions. But D'Adderio finds it 'difficult to see AI entirely replacing clinicians, if not for the simplest tasks.' Who (or What) Do You Trust? In a recent Medscape interview, tech executive Peter Diamandis told the story of a close friend and colleague who felt ill and had seen several doctors over a period of months. No conclusive diagnosis was made until finally one doctor correctly diagnosed him with lymphoma. When he got this news, his friend 'took his data from 3 months earlier and fed it into Claude 3.7 for a differential diagnosis,' says Diamandis. 'And lymphoma was number one on the list. From 3 months earlier. So I tell people, grab your data [and] get…not a second opinion — get an AI opinion. [T]hat's going to become more and more common.' That crystalizes the current debate about AI today and what AI could one day become: Do you trust your doctor? Or do you trust a machine to get it right? Big AI trust issues remain, especially with algorithms trained on online text, which could span everything from data taken from the Centers for Disease Control and Prevention and a thread shared on X. 'Ensuring factual accuracy and mitigating misinformation are critical research priorities for medical AI,' says Schaekermann, who claims AMIE only focuses on authoritative knowledge sources, such as curated medical datasets, clinical practice guidelines, and drug formularies, 'rather than learning uncontrollably from the open internet.' But it's not just about the misinformation creeping into AI algorithms. Before they can be deployed in hospitals and used on patients, AI vendors need to undergo stringent quality and performance validation. But once approved, 'AI algorithms are 'frozen,' meaning that they cannot be allowed to change, or to learn from the data they process,' says D'Adderio. What's more, AI algorithms are tested based on databases 'which may or may not represent the patient population in the hospital where they are adopted,' says D'Adderio. 'For example, the software might have been tested against an east European sample population and be used in a UK hospital. This means algorithms are inherently biased and need to be retested every time they are implemented at a new hospital site to verify their performance against the hospital's actual patient population.' A 2024 Harvard study of GPT-3's diagnostic and triage ability found that AI could make the correct diagnosis 88% of the time, compared with 96% among human physicians (when given the same prompts). But the tool's accuracy was dependent on patient descriptions of their symptoms. Explanations that were poorly worded or lacked critical information — something a human doctor would be more likely to make sense of — caused AI to make more mistakes. There's also the question of whether patients will want to share medical information with a chatbot rather than a flesh-and-blood person. A 2023 Pew survey found that 60% of Americans 'would feel uncomfortable if their own health care provider relied on artificial intelligence to do things like diagnose disease and recommend treatments.' That same year, the mental health app Koko experimented with GPT-3 to compose encouraging messages for their 4000 users. But according to Koko cofounder Rob Morris, who shared his thoughts on X, although the tech did allow them to interact more quickly and efficiently, users weren't impressed. The 'simulated empathy feels weird, empty,' Morris wrote. 'Machines don't have lived, human experience, so when they say 'that sounds hard' or 'I understand,' it sounds inauthentic.' Humans and AI, Better Together Some researchers warn that replacing physicians with AI runs the risk of 'Turing trap thinking,' says Nigam Shah, MBBS, PhD, professor of medicine at Stanford University and chief data scientist for Stanford Health Care. The Turing test, first proposed by computer scientist Alan Turing in 1950, suggested that if a machine can provide an answer that makes it indistinguishable from a human, then and only then can it be described as 'intelligent.' Nigam Shah, MBBS, PhD In 2023, Shah and his colleagues took a closer look at this theory in a medical setting, studying whether 430 volunteers could tell the difference between ChatGPT and a flesh-and-blood doctor. On average, patients correctly identified both the real doctor and their AI equivalent just 65% of the time. And they were less likely to trust a chatbot's diagnosis for high-risk or complex questions. Rather than trying to outperform or replace humans, Shah says, the focus should be on how AI can complement human work. 'Today's thinking seems to imagine the human as either an overwatch — to catch AI's error — or an impediment to full value of AI,' he says. 'We need to ask the question: What are optimal human-AI teaming set-ups? Maybe AI does the screening to reduce human labor.' The ideal integration of AI into medical diagnostics might involve finding how these two very unique kinds of expertise — the machine's ability to rapidly detect emergent patterns drawing on vast amounts of data, and human clinical judgement — can work together seamlessly. Even in another 25 years, 'humans will remain fundamental for complex diagnoses,' D'Adderio says. 'AI is not infallible; we still require clinicians to retrospectively verify the accuracy of its determinations.' Mahmood's recent research on AI models for pathology, such as UNI and CONCH, has demonstrated how the technology can enhance diagnostic accuracy by leveraging large-scale datasets. His hope is that this will eventually allow for 'a more holistic and scalable approach to rare disease diagnosis,' he says. But Schaekermann points out that even as AI becomes more sophisticated, with deeper reasoning and multimodality, 'we envision the technology primarily enhancing, not replacing, clinicians,' he says. 'Especially for complex interactions like checkups that rely heavily on human judgment, empathy, and the provider-patient relationship. The goal is for AI to handle specific tasks, freeing clinicians to focus on the human aspects of care.' Shah recommends that any medical student hoping for a lasting career should do more than just familiarize themselves with data science and mathematics. It needs to become an academic priority. 'Many high school students are already developing good data sense,' he says. 'Which will position them very well to operate in the technology-heavy medical world of the future.' Jesse Ehrenfeld, MD, former president of the American Medical Association, puts it more succinctly: ' AI is not going to replace doctors,' he says, 'but doctors using AI will replace doctors who aren't using AI.'
